Redhill Biopharma
RDHL
#10544
Rank
NZ$6.67 M
Marketcap
NZ$1.31
Share price
-4.86%
Change (1 day)
-73.31%
Change (1 year)

Redhill Biopharma (RDHL) - Total liabilities

Total liabilities on the balance sheet as of June 2025 : NZ$39.64 Million

According to Redhill Biopharma's latest financial reports the company's total liabilities are NZ$39.64 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Redhill Biopharma - Total liabilities on balance sheet (from 2011 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31NZ$40.29 M21.48%
2023-12-31NZ$33.17 M-89.84%
2022-12-31NZ$0.32 B29.41%
2021-12-31NZ$0.25 B9.41%
2020-12-31NZ$0.23 B1001.61%
2019-12-31NZ$20.93 M25.08%
2018-12-31NZ$16.73 M-3.2%
2017-12-31NZ$17.28 M4.03%
2016-12-31NZ$16.61 M68.47%
2015-12-31NZ$9.86 M101%
2014-12-31NZ$4.9 M66.98%
2013-12-31NZ$2.93 M124.27%
2012-12-31NZ$1.31 M-26.9%
2011-12-31NZ$1.79 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Sanofi
SNY
NZ$112.61 B 283,929.05%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
NZ$146.51 B 369,426.48%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$105.82 B 266,809.20%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
NZ$57.13 B 143,990.93%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Taro Pharmaceutical
TARO
NZ$0.66 B 1,585.55%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel